Titan Pharma (TTNP) on Watch After Braeburn Pharmaceuticals Announces Commercialization Plans for Probuphine Implant
Tweet Send to a Friend
Titan Pharma (NASDAQ: TTNP) declined post-market following a press release from Braeburn PharmaceuticalsPress release:Braeburn Pharmaceuticals announces plans to make Probuphine ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE